This page includes the latest FDA filings for Tasman Pharma Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2023-12-15 |
| Tasman Pharma Inc. | Prescription Medication | 2023-12-15 |
| Tasman Pharma Inc. | Prescription Medication | 2022-10-29 |
| Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-10-27 |
| Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-04-01 |
| Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-03-29 |
| Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-03-03 |
| Tasman Pharma Inc. | Betamethasone Dipropionate USP, 0.05% | 2022-02-18 |
| Tasman Pharma Inc. | Prescription Medication | 2021-11-25 |
| Tasman Pharma Inc. | Ketoconazole Cream, 2% | 2021-11-17 |
| Tasman Pharma Inc. | Prescription Medication | 2021-02-21 |
| Tasman Pharma Inc. | Fluocinolone Acetonide Oil, 0.01% (Ear Drops) | 2021-02-05 |
| Tasman Pharma Inc. | Prescription Medication | 2021-01-12 |
| Tasman Pharma Inc. | Prescription Medication | 2019-08-06 |
| Tasman Pharma Inc. | Clotrimazole Topical Solution USP, 1% | 2019-07-25 |